392 related articles for article (PubMed ID: 1665407)
1. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
[TBL] [Abstract][Full Text] [Related]
2. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
[TBL] [Abstract][Full Text] [Related]
3. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
[TBL] [Abstract][Full Text] [Related]
4. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
[TBL] [Abstract][Full Text] [Related]
5. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
[TBL] [Abstract][Full Text] [Related]
6. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
Jenkins DA; Cowan P; Patrick AW; Clarke BF
Nephrol Dial Transplant; 1993; 8(3):200-5. PubMed ID: 8385284
[TBL] [Abstract][Full Text] [Related]
7. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
8. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
9. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
Cooper ME
J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
[TBL] [Abstract][Full Text] [Related]
10. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure reduction as a preventive treatment of diabetic nephropathy.
Ribstein J; Mimran A
Clin Invest Med; 1991 Dec; 14(6):661-70. PubMed ID: 1794216
[TBL] [Abstract][Full Text] [Related]
12. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.
Poulsen PL
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749
[TBL] [Abstract][Full Text] [Related]
14. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
15. Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy.
Pedersen MM; Hansen KW; Schmitz A; Sørensen K; Christensen CK; Mogensen CE
Kidney Int; 1992 Apr; 41(4):883-90. PubMed ID: 1355149
[TBL] [Abstract][Full Text] [Related]
16. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
Björck S
Scand J Urol Nephrol Suppl; 1990; 126():1-51. PubMed ID: 2194280
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive treatment inhibiting the progression of diabetic nephropathy.
Mogensen CE
Acta Endocrinol Suppl (Copenh); 1980; 238():103-8. PubMed ID: 6933807
[TBL] [Abstract][Full Text] [Related]
18. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
Abu-Romeh SH; Nawaz MK; Ali JH; Al-Suhaili AR; Abu-Jayyab AK
Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
[TBL] [Abstract][Full Text] [Related]
19. Nephroprotection by antihypertensive agents.
Schmieder RE
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.
Nielsen SE; Persson F; Frandsen E; Sugaya T; Hess G; Zdunek D; Shjoedt KJ; Parving HH; Rossing P
Diabet Med; 2012 Aug; 29(8):e184-90. PubMed ID: 22268920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
